References
- Travaglino E, Benatti C, Malcovati L, . Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes. Eur J Haematol 2008;80:216–226.
- Somerville RP, Oblander SA, Apte SS. Matrix metalloproteinases: old dogs with new tricks. Genome Biol 2003;4:216.
- Figueira RC, Gomes LR, Neto JS, . Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer 2009;9:20.
- Ries C, Loher F, Zang C, . Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Clin Cancer Res 1999;5:1115–1124.
- de Bont ES, Rosati S, Jacobs S, . Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor. Br J Haematol 2001;113: 296–304.
- Lambert E, Dasse E, Haye B, . TIMPs as multifacial proteins. Crit Rev Oncol Hematol 2004;49:187–198.
- Kuvaja P, Wurtz SO, Talvensaari-Mattila A, . High serum TIMP-1 correlates with poor prognosis in breast carcinoma – a validation study. Cancer Biomark 2007;3:293–300.
- Hatfield KJ, Reikvam H, Bruserud O. The crosstalk between the matrix metalloprotease system and the chemokine network in acute myeloid leukemia. Curr Med Chem 2010;17:4448–4461.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402–408.
- Jezierska A, Motyl T. Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med Sci Monit 2009;15: RA32–RA40.
- Kuittinen O, Savolainen ER, Koistinen P, . MMP-2 and MMP-9 expression in adult and childhood acute lymphatic leukemia (ALL). Leuk Res 2001;25:125–131.
- Devy L, Hollender P, Munaut C, . Matrix and serine protease expression during leukemic cell differentiation induced by aclacinomycin and all-trans-retinoic acid. Biochem Pharmacol 2002;63:179–189.
- Shen Y, Winkler IG, Barbier V, . Tissue inhibitor of metalloproteinase-3 (TIMP-3) regulates hematopoiesis and bone formation in vivo. PLoS One 2010;5. pii: e13086.
- Samara GJ, Lawrence DM, Chiarelli CJ, . CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma. Cancer Lett 2004;214:231–241.
- Grymula K, Tarnowski M, Wysoczynski M, . Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas. Int J Cancer 2010;127:2554–2568.
- Beider K, Begin M, Abraham M, . CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth. Exp Hematol 2011;39:282–292.